Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Genzyme

Founders George Whitesides Sheridan Snyder

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$190M
Portfolio companies 4
Rounds per year 0.10
Lead investments 3
Exits 3
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Genetics
Summary

In 1981 was created Genzyme, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The leading representative office of defined Corporate Investor is situated in the Cambridge.

This Genzyme works on 46 percentage points more the average amount of lead investments comparing to the other organizations. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2008. The real fund results show that this Corporate Investor is 55 percentage points more often commits exit comparing to other companies. The increased amount of exits for fund were in 2017.

The fund has no exact preference in a number of founders of portfolio startups. When startup sums 1 or 3 of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most popular portfolio startups of the fund, we may highlight Voyager Therapeutics, Peptimmune, Alnylam Pharmaceuticals. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular fund investment industries, there are Pharmaceutical, Genetics.

The fund was created by George Whitesides, Sheridan Snyder.

The typical case for the fund is to invest in rounds with 4 participants. Despite the Genzyme, startups are often financed by MPM Capital, Vanguard Ventures, Sofinnova Investments. The meaningful sponsors for the fund in investment in the same round are MPM Capital, Vanguard Ventures, Sofinnova Investments. In the next rounds fund is usually obtained by MPM Capital, Silicon Valley Bank, New Enterprise Associates.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Genzyme:
Typical Co-investors
Genzyme is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Genzyme:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Agile Venture Capital California, San Francisco, United States
Arba Seed Investment Group California, San Francisco, United States
Do Ventures Jamaica, Saint James, Vietnam
Eminence Ventures China, Shanghai
Innovative Medical Management Anaheim, California, United States
L1 Digital Switzerland, Zürich, Zurich
Lytical Ventures New York, New York, United States
Madison Alley Global Ventures New York, New York, United States
P5 Health Ventures Connecticut, Fairfield, United States
Project Music Nashville, Tennessee, United States
Shalom Equity Fund -
Shanghai International Group (SIG) China, Shanghai
Spectre California, Irvine, United States
SRM Holdings -
Star Mica Japan, Tokyo
Xi'an Investment Holding China, Hunan, Xian
Xinyu Renzhi Touzi Guanli Zhongxin China, Jiangxi, Xinyu

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

2AF Stores

Biotechnology
Medical
Pharmaceutical
$12M07 Jun 2006 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Genzyme?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 190M
Rounds per year 0.10
Peak activity year 2015
Lead investments 3
Exits 3
Group Appearance index 0.50

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

2AF Stores

Biotechnology
Medical
Pharmaceutical
$12M07 Jun 2006 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: